The MARS Diagnostic Assessment is used to assess whether an individual has memory loss and, if so, to determine the etiology of the memory loss if possible.

Physicians should refer individuals for the MARS Diagnostic Assessment if they suspect the individual may be experiencing memory loss. Suspicion can arise from patient complaints, family complaints, or the physician’s own observations. We caution physicians not to rely on a poor performance on the short screens before referral. Short screens are relatively insensitive to early stage dementia.

Detecting memory loss in its earliest stages is critical to ensure the best patient outcome.

Early detection of memory loss, similar to that of other progressive diseases like cancer, gives the patient a treatment advantage. The drugs available today for treatment of dementia slow the progression of the disease symptoms. Therefore, if one catches memory loss early, aggressive treatment can provide the patient extra quality years.

The MARS Diagnostic Assessment consists of a standardized set of the most valid and reliable assessments available for measuring the cognitive functioning of adults.

These assessments are sensitive enough to detect memory loss at its earliest stages and broad enough to allow for differential diagnoses. The MARS Diagnostic Assessment includes assessments of psychological states, such as depression, that can mimic memory disease, as well as comprehensive functional assessments of memory systems. The MARS Diagnostic Assessment includes testing and a clinical interview.

The MARS staff understands the challenges involved for older individuals with memory loss. We help our clients feel comfortable, relaxed, and at ease while they are with us.

MARS Memory-Health Network